| 摘要 |
The invention relates to the use of a substance which reduces the circulating levels of lactate and neurotoxic excitatory amino acids, for the treatment or prevention of a pathologic condition involving neurological injury. Such substance may be glucagon, insulin or any combination or mixture thereof. The invention further provides methods and compositions for protecting the central nervous system (CNS) from injury and death, which may result from, for example, a head trauma, a stroke or a neurodegenerative disorder, using glucagon, insulin or any combination or mixture thereof which reduce the levels of circulating lactate and neurotoxic excitatory amino acids. |
